Alexion’s Ondexxya approved for NHS Scotland to treat uncontrolled and life-threatening bleeds
September 9, 2020Research and Development, Sales and Marketing Alexion, NHS, Ondexxya, Scotland, nhs scotland
The Scottish Medicines Consortium (SMC) has given its recommendation to Alexion’s Ondexxya (andexanet alfa) to routine use on NHS Scotland …
AstraZeneca slams brakes on COVID-19 vaccine trial over unexplained participant illness
September 9, 2020Research and Development AstraZeneca, COVID-19, pharma
Global trials for AstraZeneca’s much-hyped COVID-19 vaccine, currently in development in partnership with the University of Oxford, have been halted …
Gatherings of over six people to be banned in England from Monday
September 9, 2020Research and Development Lockdown, coronavirus
England is set to increase lockdown restrictions across the country after a surge in coronavirus cases. Currently, most outdoor gatherings …
Roche to start new trials of Ocrevus to defend multiple sclerosis franchise
September 9, 2020Research and Development MS, MS drug, Roche
Roche is to begin expanding trials of Ocrevus in multiple sclerosis (MS) patients to defend its MS franchise from its …
Major vaccine manufacturers sign COVID-19 safety pledge
September 9, 2020Research and Development CDC, FDA, anti vaxx, anti-vaxx, coronavirus vaccine
Nine vaccine manufactures have signed a pledge to uphold ethical standards while producing their treatments for COVID-19. The companies involved …
FibroGen names appointment for newly created Chief Scientific Officer role
September 8, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, fibrogen
FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …
Advaxis Chief Financial Officer resigns
September 8, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Advaxis
Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …
Takeda to sell another non-core portfolio for $260 million to Cheplapharm
September 8, 2020Manufacturing and Production, Sales and Marketing Cheplapharm, Takeda, pharma
Takeda has revealed it has agreed to divest its non-core portfolio of prescription therapies to Cheplapharm in exchange for an …
Extension study reveals Dupixent’s benefit can last up to three years in moderate-to-severe asthma
September 8, 2020Manufacturing and Production, Research and Development Dupixent, Sanofi, asthma, pharma
New findings have been revealed from an extension study of Sanofi’s interleukin-4 (IL-4) and interleukin-13 (IL-13) inhibitor Dupixent (dupilumab) in …
Mylan reaches agreement with Aspen for their European thrombosis business
September 8, 2020Manufacturing and Production Mylan, aspen
Mylan has announced an agreement to acquire the intellectual property and commercialisation rights to Aspen’s thrombosis business for €641.9 million. …
Chinese drug firm says thousands have been vaccinated for COVID-19 on an emergency use scheme
September 8, 2020Manufacturing and Production China Vaccine, China Vaccine approval, coronavirus vaccine
Hundreds of thousands of people in China have been inoculated with two experimental vaccines on an emergency use scheme, according …
Up to 60,000 in the UK may have suffered from “long COVID” new data suggests
September 8, 2020Manufacturing and Production Vaccine, pandemic, vaccines
60,000 people across Britain may have been suffering from prolonged symptoms of coronavirus months after contracting the virus. This is …
Genetech scores sixth FDA approval in lung cancer with Gavreto
September 7, 2020Sales and Marketing Cancer, FDA, Genentech, lung cancer
Genentech’s once-daily oral therapy Gavreto (pralsetinib) has secured FDA backing in the treatment of metastatic rearranged during transfection (RET) fusion-positive …
President of Sanofi France expects COVID-19 vaccine to be priced below ten Euros
September 7, 2020Sales and Marketing COVID-19, GSK, Sanofi
The President of Sanofi France expects the coronavirus vaccine it is developing with GlaxoSmithKline to be priced under 10 Euros. …
Janssen’s Imbruvica secures label expansion in Europe in chronic lymphocytic leukaemia
September 7, 2020Sales and Marketing Europe, Janssen, imbruvica, pharma
The European Commission (EC) has moved to expand the existing approval of Janssen’s Imbruvica (ibrutinib) in chronic lymphocytic leukaemia (CLL) …
FDA rejects oleandrin as a dietary supplement, after being touted by major Trump ally as a coronavirus treatment
September 7, 2020Sales and Marketing FDA, coronavirus, fda treatment
The FDA has rejected a submission from Phoenix Biotechnology to market oleandrin as a dietary supplement. Phoenix Biotechnology submitted oleandrin …
New poll indicates most Americans will not get a COVID-19 vaccine when it’s first available
September 7, 2020Sales and Marketing COVID, COVID-19, COVID-19 vaccine, coronavirus
Two-thirds of Americans say they will not get vaccinated against COVID-19 when a treatment first becomes available, according to a …
Meta-analysis reinforces efficacy of commercially available steroids in hospitalised COVID-19 patients
September 4, 2020Medical Communications, Research and Development COVID-19, pharma, steroids
A new meta-analysis of seven studies worldwide investigating the benefit for commercially available steroid therapies in the treatment of COVID-19 …
Operation Warp Speed’s top doctor says coronavirus vaccine likely won’t be approved until after November
September 4, 2020Medical Communications
Dr Moncef Slaoui, the leading doctor involved with Operation Warp Speed, has said it is unlikely a vaccine for the …
Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters
September 4, 2020Medical Communications COVID-19, J&J, JJ
Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters.
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
